Ulisse Biomed Balance Sheet Health
Financial Health criteria checks 3/6
Ulisse Biomed has a total shareholder equity of €5.0M and total debt of €9.1K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are €5.7M and €698.5K respectively.
Key information
0.2%
Debt to equity ratio
€9.10k
Debt
Interest coverage ratio | n/a |
Cash | €2.91m |
Equity | €5.05m |
Total liabilities | €698.50k |
Total assets | €5.75m |
Financial Position Analysis
Short Term Liabilities: UBM's short term assets (€4.1M) exceed its short term liabilities (€277.4K).
Long Term Liabilities: UBM's short term assets (€4.1M) exceed its long term liabilities (€421.1K).
Debt to Equity History and Analysis
Debt Level: UBM has more cash than its total debt.
Reducing Debt: Insufficient data to determine if UBM's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if UBM has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if UBM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.